Prosperity Capital Management Issues Open Letter to Petropavlovsk Shareholders Regarding ISS Recommendations
Prosperity Capital Management (“Prosperity”), a leading Russia-focused asset manager that controls approximately 20 per cent of the outstanding share capital of Petropavlovsk PLC (“the Company”), today issued the following public letter to Petropavlovsk shareholders regarding the voting recommendations made by leading independent proxy advisor Institutional Shareholder Services (“ISS”). The overwhelming majority of institutional shareholders receive ISS’ advice.
Fellow Petropavlovsk shareholders,
We are pleased that ISS has recommended that shareholders vote in line with Prosperity’s proposals and for a strong, independent and balanced Board at Petropavlovsk’s Extraordinary General Meeting (“EGM”) to be held on 10 August. In their analysis they conclude:
- VOTE FOR the six highly qualified director nominees nominated by Prosperity – represented by Resolutions 1-6 – “as the election of those directors provides the best possible alternative for protecting the interest of minority shareholders”;
- VOTE AGAINST the election of Everest Alliance Limited’s (“Everest”) nominees – Resolutions 7-8 – “given the insufficient rationale provided by the proponent”; and
- VOTE AGAINST Resolution 18, “which effectively provides for the removal with immediate effect of any of the director candidates nominated by Prosperity”.
It is clear that this independent proxy advisor recognises the risk posed to shareholders by Everest’s proposals and believes that the Company and its shareholders deserve a strong, independent, and balanced Board that can create sustainable value.
We are pleased with the opinions that ISS has shared, which align with our view that:
- “From a minority shareholder perspective, the main concern at present is the possibility that a small group of shareholders, including the Company's competitor and largest shareholder UGC, Everest and the parties allegedly acting in concert with them, takes control of the Company without paying a control premium or negotiating a transaction that is in the best interest of all shareholders.”
- “In the context of the current situation and based on the available information at the time of publication of this report, and considering that five of the six PCM [Prosperity] nominees are independent and four of the six are among those unanimously recommended for (re)election by the Board for the 2020 AGM, we believe that the election of PCM [Prosperity] nominated directors provides the best possible alternative for protecting the interest of minority shareholders.”
- “This [electing the Prosperity nominees] will ensure a well-balanced and majority independent board is in place and provide the possibility for an optimal resolution of the shareholder stand-off.”
It is clear that ISS has seen Everest’s proposals for what they really are: A vehicle to effect a creeping takeover of the Company. In an underhand manner, a group of concert parties led by JSC Uzhuralzoloto Group of Companies (“UGC”) and Everest indicated support for the existing Board, management and governance structure (through their own elected Board nominees/representatives) and then voted the exact opposite way at the Company’s 30 June 2020 Annual General Meeting (“AGM”), taking advantage of most shareholders being unaware and as a result successfully removed most of the Board and aligned it to their interests. This group of concert parties will collectively control not less than 35% and likely above 40% of Petropavlovsk’s outstanding shares at the EGM (subject to bond conversion and other factors).
Whilst the concert parties have not formally stated their strategic intentions for Petropavlovsk, it is obvious from their actions, relationships, public remarks and other available information that they intend to take control of the Board and management of our Company and then execute a merger or other combination between Petropavlovsk and UGC without paying a control premium to Petropavlovsk’s shareholders. We have formalised our objection to this with the Takeover Panel.
The concerted parties’ actions prior to and at the Company’s AGM make this clear:
- Prior to the AGM, UGC board representative Maxim Kharin was amongst the directors of Petropavlovsk’s Board to unanimously approve the AGM agenda, including the reelection of all incumbent directors.
- UGC subsequently reneged on its Board representative’s commitment so as to remove seven existing directors – including more senior directors and the Company’s co-founder and CEO, under whose combined leadership the Company has created tremendous value over recent years, achieving sales and production growth while reducing net debt and improving cash flow.
- This enabled the concert parties to install their own hand-picked representatives and one directly affiliated nominee, creating a sympathetic Board designed to give control of the Company to them and at the same time putting Petropavlovsk’s Premium Listing status and independence at risk.
Following these dramatic and unfortunate events, we felt that it was our responsibility as a significant, long-term, minority shareholder owning approximately 20 per cent of Petropovlavsk’s common stock to correct the situation to ensure that Petropavlovsk retains an independent Board that works in the best interests of all shareholders. We therefore requisitioned the EGM and nominated a slate of six professional and independent candidates to be added to the four directors elected at the AGM. We believe that the small board formed at the AGM lacked independence and requires strengthening and balance in keeping with best practice corporate governance in the UK.
Subsequently, Everest has not only proposed the election of two additional hand-picked directors at the EGM, it has also cynically proposed Resolution 18.
If passed, this resolution would immediately remove all of the director nominees that we have proposed if they are elected at the EGM. Resolution 18 is plainly dangerous for other shareholders and perversely designed to obfuscate and frustrate the will of the majority of shareholders by creating an almost unimaginable scenario in which one could vote for appointment of a director and their removal in the same meeting. This is further evidence of Everest’s efforts to subordinate other shareholders. The Interim Board and ISS have strongly cautioned shareholders about the deceptive implications of Resolution 18, and it is critical that shareholders vote AGAINST it at the EGM in addition to voting AGAINST Resolutions 7 and 8 proposing the election of Everest’s nominees.
We believe that the transparency, independence and experience of Prosperity’s nominees stands in stark contrast to Everest’s nominees, whom ISS have recommended that shareholders vote against. We have good reason to believe that, at a minimum, at least one of Everest’s candidates has direct business links to UGC. Nominee Ivan Kulakov and UGC founder and President Konstantin Strukov have a long-term friendship and have recently been engaged in certain business agreements recently. Additionally, in contrast to our nominees’ commitment to transparency, Everest has been unwilling to submit its candidates to the Professional Investor Association’s vetting process.
It is critical that you follow our appeal and ISS recommendations and VOTE FOR Resolutions 1 - 6 and VOTE AGAINST Resolutions 7, 8 and 18 at the EGM. As ISS has highlighted, this vote is about preserving the independence of our Company, maintaining a strong and professional Board that is able to resist any inappropriate pressure to sell the company on the cheap and that will maximise value for all shareholders. The ongoing development of the Company and any bid for the Company should be considered independently, in the interests of all shareholders and certainly not by a small board aligned to a potential suitor.
For more information, including instructions on how to vote your shares, please visit www.Stop-Takeover-Of-POG.com.
The choice is ours.
Prosperity Capital Management
About Prosperity Capital Management
Founded in 1996, Prosperity Capital Management is a leading Russia-focused asset manager controlling assets of around USD 4 billion on behalf of pension funds, endowments, foundations, family offices, sovereign wealth funds and high net worth individuals from across Europe, North America, Middle East and Australasia. The firm employs a long-term, fundamental value, active and engaged shareholder approach to access the public equity investment opportunity amongst Russian and Former Soviet Union companies.
+44 7989 528421
+44 7551 720441
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Global Initiates Expansion into Albania28.10.2020 14:30:00 CET | Press release
Andersen Global continues to focus on its expansion strategy in the European region with the addition of KALO & ASSOCIATES in Albania. The firm, founded in 1994 by Managing Partner Perparim Kalo, is a leading law firm in Albania. With a team of eight Partners and 30 professionals, the firm has proven capabilities in banking and finance, corporate, commercial litigation and arbitration, employment, tax, infrastructure, intellectual property, and real estate. In addition to working with large projects and investors and IFIs, including a number of Fortune 500 companies, the firm has contributed to the development of a modern commercial legislation and regulatory framework through involvement in the drafting of laws on secured transactions, financial leasing, pension funds, collective investment funds, telecommunications, concessions, renewable energy and energy efficiency. Additionally, the firm is highly ranked by IFLR1000,Chambers and Legal 500. “As the business environment continues to
Sevan Completes 28,000 Surveys, Reaches Major Milestone28.10.2020 14:00:00 CET | Press release
Sevan Multi-Site Solutions, Inc. (Sevan) — a global leader in innovative design, program management, construction services and data analytics — has reached a significant milestone. The company has completed 28,000surveys, adding up to more than 700 million square feet since Sevan’s inception in 2011. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005437/en/ Sevan completes 28,000 surveys, reaches major milestone. More than 700 million square feet surveyed. (Graphic: Business Wire) “Sevan’s surveys have become a thread that runs through many of our program management offerings,” President and CEO Jim Evans said. “One of our strongest traits as a company is that we tailor to the needs of our clients, customize innovative solutions and deliver excellence. It has been incredible to see the growth of our surveys and technology offerings in the past years, and we are grateful we have the opportunity to contribute to the succ
Synergis Adept Named #1 in 21 Rankings on G2’s 2020 Fall Grid Reports28.10.2020 13:21:00 CET | Press release
Synergis Software, a global leader in engineering information management and product data management (PDM), today announced that its flagship product, Adept, has earned 21 top placements in G2 Crowd’s Fall 2020 Grid Reports. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005422/en/ Synergis Adept earns 21 top honors on G2 Crowd's 2020 Fall Grid Reports. (Graphic: Business Wire) The reports, which are based on real customer reviews, highlight Adept’s leadership in ease of use, ease of setup, fastest implementation, best support and best relationship as some of the key differentiators compared to other products on the market. Adept earned Leader status in Product Data Management (PDM) and Enterprise Content Management (ECM), and High Performer status in Construction Drawing Management. “We're committed to helping clients become more efficient, secure and collaborative, and reports like this help us understand what we're
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-1928.10.2020 13:20:00 CET | Press release
Boehringer Ingelheim today announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and selective inhibitor of TRPC6 may alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in patients hospitalized for COVID-19. The aim of therapy with BI 764198 is to reduce the need for ventilator support, to improve patient recovery rate and ultimately to save lives. Boehringer Ingelheim is committed to fighting COVID-19 and contributing with its expertise and resources to develop new therapeutic options for patients suffering from the virus’ severe complications. “COVID-19 can cause serious lung complications, such as viral pneumonia, and in severe cases can lead to acute respiratory distress syndrome (ARDS) and lung failure,” said Dr. Lorraine B. Ware, Ralph and Lulu Oven Endowed Chair and Professor of Medicine, and Pathology, Microbiology and Immunology, Vanderbilt Uni
First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP28.10.2020 13:03:00 CET | Press release
Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pump in the world. It measures 9 French (Fr) (3 millimeters) in diameter upon insertion and removal from the body. While in the heart, it expands while supporting the heart’s pumping function, providing peak flows greater than 3.5 L/min. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005398/en/ Impella ECP is the world’s smallest heart pump. (Graphic: Business Wire) The first Impella ECP patient was treated by Amir Kaki, MD, an interventional cardiologist and director of mechanical circulatory support at Ascension St. John Hospital in Detroit, part of Ascension Michigan. The patient had severe narrowing of his coronary arteries. Dr. Kaki successfully opened the patient’s arteries by performing several percutaneous interventions with support from Impella ECP
Alira Health and Embleema Announce Partnership to Deploy Next-Generation Real-World Data Solutions for Life Sciences28.10.2020 13:00:00 CET | Press release
Alira Health, a leading international healthcare and life sciences advisory firm, and Embleema, the innovative software provider for patient-driven healthcare data platforms, today announced a strategic partnership to develop next-generation real-world data solutions aimed at accelerating clinical innovation and improving patient outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005026/en/ "Our partnership with Embleema is a critical step in the further development of our real-world evidence capabilities, which connects clinical research, hospital care, and the patient experience,” says Gabriele Brambilla, Chief Executive Officer of Alira Health. Romain Finas, VP of Real World Evidence at Alira Health, adds, “We are excited to offer our clients new solutions for real-world data, which will empower them to better evaluate their treatments and deliver new innovations to patients more quickly.” Robert Chu, Chief Ex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom